Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.018 | 0.7 |
mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.019 | 0.7 |
mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |